BioNTech SE (BNTX) Inventory (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Inventory data on file, last reported at $128.9 million in Q4 2025.

• In Q4 2025, Inventory fell 57.43% year-over-year to $128.9 million; the TTM figure through Dec 2025 stood at $128.9 million (down 57.43% YoY), while the FY2025 annual figure was $125.1 million, down 58.69% from the prior year.
• Inventory slipped to $128.9 million in Q4 2025, from $263.9 million in the prior quarter.
• Across five years, Inventory topped out at $12.5 billion in Q3 2021 and bottomed at $128.9 million in Q4 2025.
• A 5-year average of $2.0 billion and a median of $416.7 million in 2022 frame the typical range for Inventory.
• Annual changes were most pronounced in 2021 — Inventory surged 31061.78% — and 2022, when it tumbled 97.62%.
• Year by year, Inventory stood at $574.8 million in 2021, then decreased by 21.98% to $448.5 million in 2022, then slipped by 14.19% to $384.9 million in 2023, then declined by 21.34% to $302.7 million in 2024, then slumped by 57.43% to $128.9 million in 2025.
• The last three Inventory figures came in at $128.9 million (Q4 2025), $263.9 million (Q3 2025), and $261.1 million (Q2 2025), per Business Quant data.

Peer Comparison